Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss-Reference-Cited by-同舟云学术

Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss

Published:2016-06-17 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Cheng Tsung-Lin,Lai Chao-Han,Shieh Shyh-Jou,Jou Yin-Bo,Yeh Jwu-Lai,Yang Ai-Lun,Wang Yan-Hsiung,Wang Chau-Zen,Chen Chung-Hwan,Shi Guey-Yueh,Ho Mei-Ling,Wu Hua-Lin

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep28340.pdf

Reference50 articles.

1. Yasuda, H. et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95, 3597–3602 (1998).

2. Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165–176 (1998).

3. Nakagawa, N. et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253, 395–400, 10.1006/bbrc.1998.9788 (1998).

4. Arron, J. R. & Choi, Y. Bone versus immune system. Nature 408, 535–536, 10.1038/35046196 (2000).

5. Dittman, W. A. & Majerus, P. W. Structure and function of thrombomodulin: a natural anticoagulant. Blood 75, 329–336 (1990).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms;Frontiers in Oncology;2024-07-26

2. Production of a p65^fl/fl/LysMCre mouse model with dysfunctional NF-κB signaling in bone marrow-derived macrophages;Innate Immunity;2023-10-13

3. Chondrocyte Thrombomodulin Protects against Osteoarthritis;International Journal of Molecular Sciences;2023-05-30

4. Soluble CD93 lectin-like domain sequesters HMGB1 to ameliorate inflammatory diseases;Theranostics;2023

5. The interplay between hemostasis and immune response in biomaterial development for osteogenesis;Materials Today;2022-04